Registry participation is worldwide and not limited to this facility — Cambridge, Massachusetts

Registry participation is worldwide and not limited to this facility is a clinical research site located in Cambridge, Massachusetts, United States.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Registry participation is worldwide and not limited to this facility has participated in 1 clinical trials.

Therapeutic areas: Mastocytosis.

Sponsors: Blueprint Medicines Corporation.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Cambridge

Browse all research sites in Massachusetts · View every site in Cambridge

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Registry participation is worldwide and not limited to this facility?

Registry participation is worldwide and not limited to this facility has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Registry participation is worldwide and not limited to this facility conducted?

Registry participation is worldwide and not limited to this facility has 1 clinical trials on record. Their work covers Mastocytosis.

Is Registry participation is worldwide and not limited to this facility accredited by Crixeo Clinical Trials?

Registry participation is worldwide and not limited to this facility has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Registry participation is worldwide and not limited to this facility?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.